Jefferson Health
We Improve Lives

Jefferson and Novartis Pharmaceuticals Corporation are "Closing the Gap," a 3-year initiative designed to address risk factors for cardiovascular disease and break down barriers that inhibit access to care.

Our Sidney Kimmel Cancer Center is launching a Mobile Cancer Screening program to better serve vulnerable populations in Greater Philadelphia.

Interested in taking a more active role in your health or gaining access to new therapies? Jefferson conducts various cutting-edge research and clinical trials that help improve treatment outcomes.

U.S. News & World Report ranked Jefferson Health Hospitals among the nation's best, according to the latest rankings.

Dr. John Zurlo, chair of the Jefferson COVID-19 Task Force offers the latest on emerging variants, return to school, booster shots and more.

Winners of the Drs. Theresa and Charles Yeo Writing Prize pen vulnerable stories about the realities of this historic pandemic and turbulent times to share with future generations.

Ovulation-inducing medications and other treatments have proven overwhelmingly successful in overriding the fertility challenge posed by PCOS.

Sarah Miranda had no reason to believe in the life-altering possibilities of genetic testing, until results turned up a mutation connected to a rare form of stomach cancer.

Understanding the signs of an overdose and knowing what to do if you believe that you are witnessing an overdose can help to save the lives of those around you.

The saying goes "you are what you eat." Here, registered dietitians advise on how food impacts short- and long-term chronic inflammation and how it can help you find relief.

The FDA’s decision to fully approve Pfizer and BioNTech’s COVID-19 vaccine marks a milestone moment in the battle against COVID-19 and optimism for the public’s vaccine confidence.

Infectious diseases physician and Chair of the Jefferson COVID-19 Task Force Dr. John Zurlo discusses everything from masking up (even when you’re fully vaccinated) to the potential of booster shots.

This notice concerns a recent security incident experienced at one of our vendors, Elekta, Inc., involving some of our patient information.